Sartorius Stedim Biotech S.A. (LON:0RG8)

Market Cap	16.44B
Revenue (ttm)	2.30B
Net Income (ttm)	144.80M
Shares Out	n/a
EPS (ttm)	1.50
PE Ratio	113.55
Forward PE	n/a
Dividend	0.59 (0.28%)
Ex-Dividend Date	Apr 2, 2024

Volume	2,432
Average Volume	47,305
Open	208.50
Previous Close	208.60
Day's Range	203.50 - 208.60
52-Week Range	115.51 - 232.58
Beta	0.72
RSI	44.08
Earnings Date	Jan 27, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management servic...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 9,901
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RG8

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial numbers in EUR